| # | Drug | Count |
|---|---|---|
| 0 | LOPINAVIR AND RITONAVIR | 15 |
| 1 | RITONAVIR | 14 |
| 2 | LAMIVUDINE | 12 |
| 3 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 11 |
| 4 | ATAZANAVIR | 9 |
| 5 | LAMIVUDINE ORAL | 9 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 9 |
| 7 | ZIDOVUDINE | 9 |
| 8 | ABACAVIR SULFATE | 8 |
| 9 | FLUCONAZOLE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTAMIDINE ISETHIONATE | 3 | 0.0024 |
| 1 | RIFABUTIN | 5 | 0.0018 |
| 2 | AMIKACIN SULFATE | 3 | 0.0017 |
| 3 | LOPINAVIR AND RITONAVIR | 15 | 0.0011 |
| 4 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 5 | ZIDOVUDINE | 9 | 0.0009 |
| 6 | ABACAVIR SULFATE | 8 | 0.0008 |
| 7 | ETHAMBUTOL HYDROCHLORIDE | 2 | 0.0007 |
| 8 | ATAZANAVIR | 9 | 0.0006 |
| 9 | RALTEGRAVIR | 3 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 5 | 0.0014 |
| 1 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 21 | 0.0003 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0003 |
| 6 | Antimalarial [EPC] | 3 | 0.0003 |
| 7 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 22 | 0.0002 |
| 9 | Sulfone [EPC] | 2 | 0.0002 |